Investigation of the effects of a new transdermal formulation of systemic diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A comparative study with oral diclofenac
DSSP is associated with a lower risk of gastrointestinal mucosal damage than DST, which has the same active ingredient but uses a different route of administration, in patients with LBP.
Authors
- Tatsuhiro Masaoka
- Koji Okawa
- Takaaki Terahara
- Seiji Futagami (ORCID: https://orcid.org/0000-0003-0502-8646)
- Takatsugu Yamamoto (ORCID: https://orcid.org/0000-0002-5337-4116)
- Tomoya Mita (ORCID: https://orcid.org/0000-0002-4401-2965)
- Yusuke Tanaka (ORCID: https://orcid.org/0000-0002-3987-1589)
- Hiroyuki Fukase (ORCID: https://orcid.org/0000-0002-3870-5351)
Institutions
- Keio University (JP)
- Kawasaki Municipal Hospital (JP)
- Nippon Medical School (JP)
- Hisamitsu Pharmaceutical (Japan) (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1111/jgh.16810
- Citations
- 2
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.90